AXXZIA, Inc. AI Stock Analysis
Want to see JP:4936 full AI Analyst Report?
AXXZIA, Inc. (4936) AI Stock Analysis
AXXZIA, Inc.
(TSE/TYO:4936)
The stock's score is primarily constrained by a severe deterioration in operational profitability, a negative P/E ratio, and a bearish technical downtrend. However, the score is partially anchored by a highly conservative, low-debt balance sheet and a 3.19% dividend yield, which provide a vital margin of safety.
AXXZIA, Inc. (4936) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 6.45B
- Dividend Yield
- 3.50%
- Average Volume (3M)
- 47.45K
- Price to Earnings (P/E)
- -14.1
- Beta (1Y)
- 0.92
- Revenue Growth
- -0.08%
- EPS Growth
- -246.12%
- Country
- Japan
- Employees
- 265
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
AXXZIA, Inc. Business Overview & Revenue Model
Company Description
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, skincare, supplements and drinks, salon care, hair care, hair styling, and beauty device products under the AXXZIA, AGtheory, LisBeau, LisBlanc, The B,...
AXXZIA, Inc. Financial Statement Overview
Summary
Despite possessing a fortress-like balance sheet with minimal debt and positive free cash flow generation, the company is severely dragged down by stagnating revenues and a sharp recent contraction into operating and net losses.
Income Statement
25NegativeBalance Sheet
85Very PositiveCash Flow
60Neutral| Breakdown | TTM | Jul 2026 | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.47B | 13.47B | 13.48B | 12.19B | 11.34B | 8.22B |
| Gross Profit | 9.95B | 9.95B | 9.92B | 9.61B | 8.94B | 6.22B |
| EBITDA | 99.04M | 30.14M | 746.64M | 1.29B | 2.06B | 1.84B |
| Net Income | -464.91M | -464.91M | 354.28M | 794.35M | 1.33B | 1.12B |
Balance Sheet | ||||||
| Total Assets | 8.94B | 8.94B | 9.62B | 10.54B | 10.70B | 10.05B |
| Cash, Cash Equivalents and Short-Term Investments | 4.00B | 4.00B | 3.99B | 4.93B | 5.79B | 6.39B |
| Total Debt | 570.96M | 570.96M | 860.67M | 975.56M | 632.25M | 654.12M |
| Total Liabilities | 1.80B | 1.80B | 2.04B | 2.01B | 1.80B | 1.66B |
| Stockholders Equity | 7.14B | 7.14B | 7.57B | 8.53B | 8.90B | 8.40B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 218.46M | 640.22M | 410.77M | 282.75M | 732.86M |
| Operating Cash Flow | 0 | 298.86M | 781.65M | 800.36M | 707.85M | 797.69M |
| Investing Cash Flow | 0 | -106.92M | -158.54M | -626.66M | -438.69M | -775.36M |
| Financing Cash Flow | 0 | -452.29M | -1.48B | -1.55B | -862.75M | 386.43M |
AXXZIA, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4936, the sentiment is Negative. The current price of 281.00 is below the 20-day moving average (MA) of 295.35, below the 50-day MA of 302.02, and below the 200-day MA of 332.82, indicating a bearish trend. The MACD of -6.45 indicates Positive momentum. The RSI at 43.34 is Neutral, neither overbought nor oversold. The STOCH value of 36.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4936.
AXXZIA, Inc. Peers Comparison
Overall Rating
JP:492580Outperform
JP:491872Outperform
JP:492665Neutral
JP:492058Neutral- JP:493651Neutral
JP:493450Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4925 | 80Outperform | JPY 6.29B | 9.25 | ― | 2.41% | 0.16% | 6.35% |
| JP:4918 | 72Outperform | JPY 1.81B | 11.68 | ― | 3.77% | -5.54% | -55.93% |
| JP:4926 | 65Neutral | JPY 5.30B | 20.87 | ― | 1.61% | 1.51% | -18.54% |
| JP:4920 | 58Neutral | JPY 2.22B | 8.32 | ― | 2.83% | 9.96% | 2053.18% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:4936 | 51Neutral | JPY 6.75B | -14.07 | ― | 3.50% | -0.08% | -246.12% |
| JP:4934 | 50Neutral | JPY 4.63B | 12.74 | ― | ― | -14.09% | -22.72% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4936 | AXXZIA, Inc. | 281.00 | -135.62 | -32.55% | |
| JP:4918 | Ivy Cosmetics Corporation | 478.00 | 163.98 | 52.22% | |
| JP:4920 | Nippon Shikizai, Inc. | 1055.00 | 2.57 | 0.24% | |
| JP:4925 | HABA Laboratories, Inc. | 1660.00 | 33.96 | 2.09% | |
| JP:4926 | C'BON COSMETICS Co., Ltd. | 1243.00 | 61.40 | 5.20% | |
| JP:4934 | Premier Anti-Aging Co., Ltd. | 532.00 | -166.00 | -23.78% |
AXXZIA, Inc. Corporate Events
AXXZIA Keeps Existing Board Lineup with Seven Director Reelections
AXXZIA Inc. has resolved at its board meeting on September 29, 2026 to propose the election of seven directors at the 15th Ordinary General Meeting of Shareholders, scheduled for October 26, 2026. All seven candidates, including President Duan Zhuo a...
AXXZIA Maintains Annual Dividend at 10 Yen Despite Net Loss
AXXZIA Inc. has approved a year-end dividend of 5 yen per share for the fiscal year ended July 31, 2026, matching the previous year’s payout and its earlier forecast. The total dividend distribution will be 114 million yen, with an effective payment...
AXXZIA Books Major Impairment, Turning Forecast Loss Much Deeper
AXXZIA Inc. reported full-year results for the fiscal year ended July 31, 2026 that were broadly in line with its earlier forecast on net sales and operating loss, with revenue of 13,466 million yen and an operating loss of 176 million yen. Ordinary...
AXXZIA Posts Loss Amid Flat Sales but Keeps Dividend and Forecasts Revenue Growth
AXXZIA Inc., a Tokyo-listed beauty and personal care company operating under Japanese GAAP, reported flat consolidated net sales of ¥13.47 billion for the fiscal year ended July 2026. The firm, known for its skincare and wellness products, continues...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 15, 2026